Roche

Hi Esma Thank you for getting in touch with us. Please submit your complaint via this contact form: accu-chek.com/contact as they will be able to support you best. Additionally, you can get in touch with our Diabetes Care office in your country to get additional guidance. Here is a link with a list of all our offices around the world: roche.com/about/business… Wishing you all the very best. Ana at Team Roche

@Roche nin accucheck cgm sine geceyim dedim Süresinden önce o sensör de bitti. Hatalı ölçümler gelmeye başladı ve bi şans daha vereyim dediğim de akşam taktığım sensor sabaha çıkmadı. Müşteri hizmetlerini aradım. 2 sini de göndereceğiz tekrar dediler. 2 diye fatura basılıp..

Cgm sensörlere nası güvencez? Bir de deli paralar ödeniyor 14-15 gün için ama yarı yolda kalıyoruz @FreeStyleLibre kullanıyorum 2 yıldır fakat 2 plusa geçtiğimden beri kullanım süresinden önce bitiyor ve ölçüm sonuçları çok farklı çıkıyor Cgm 6.5 olan ortalama hastanede 7.3 çıktı

#MEDIA - New survey demonstrates how diabetes limits day-to-day freedom for people around the world. The survey of 4,326 respondents revealed the significant mental and logistical burdens of managing diabetes, with 8 in 10 participants saying they would value predictive tools that for example can predict glucose changes before they occur. #DiabetesCare #MentalHealth #HealthTech $ROG $RHHBY

#MEDIA – We are pleased to share data from our phase III study in systemic lupus erythematosus, being presented today at #SLEuro and published in the @NEJM. This study highlights the potential of our therapy to effectively reduce disease activity for this potentially life-threatening autoimmune disease. 👉roche.com/media/releases $ROG $RHHBY

@gardp_amr Great news, thank you, @gardp_amr! By exchanging expertise and fostering dialogue, we can make meaningful strides towards combating antimicrobial resistance and advancing the development of innovative and life-saving antibiotics. Ken at Team Roche

🤝 GARDP and @Roche have signed an MoU to exchange expertise on advancing sustainable global access to innovative antibiotics. The dialogue will explore: 🌍 Access pathways for novel narrow-spectrum antibiotics 📋 Regulatory considerations 💊 Commercialization approaches that support affordability and appropriate use #AMR #GlobalHealth #AccessToMedicines

Thank you to @ISSSTE_mx in Mexico for your vision and commitment to making diagnostics a reliable guide for medical decision-making and patient care. We are honored to partner with the healthcare system and its institutions to help transform care across the country by bringing more agile and precise care to more Mexicans. #SomosRoche roche.com.mx/sala-de-prensa

#MEDIA - We’re pleased to share positive data from the third Phase III study for our investigational oral, brain-penetrant medicine in relapsing and primary progressive multiple sclerosis. roche.com/media $RHHBY $ROG

What makes sequencing by expansion (SBX) so revolutionary? With ground-breaking speed and scalability, SBX, currently in development by Roche, delivers genetic insights faster than other popular technology. More here: go.roche.com/xsbxtch #Genomics #HumanGenetics #RocheSBX #Innovation #NGS

#MEDIA – We are pleased the U.S. FDA has accepted Roche’s New Drug Application of our investigational medicine for ESR1-mutated, ER-positive, advanced #BreastCancer. This news brings us closer to making this much-needed new treatment option available. roche.com/media/releases $ROG $RHHBY

#MEDIA – We are excited to share positive results from our trial in people with primary membranous nephropathy, the first global phase III study in this chronic autoimmune disease. #MembranousNephropathy spkl.io/6018AQKJe $ROG $RHHBY

The leap to tomorrow is today! 🚀 Roche's new Diagnostics Innovation Center in Penzberg, Germany, is now officially open. This €300M investment is a massive step for innovation, designed for collaboration and digitalization to accelerate test development. Better diagnostics = better lives for patients globally: go.roche.com/leapx #Innovation #LEAP #Penzberg #Healthcare #Technology

Sequencing by expansion (SBX) is built to unlock opportunities that were once out of reach. From delivering full-length reads with unmatched speed to supporting transformative research, SBX, currently in development at Roche, sets a new benchmark for next-generation sequencing. Watch the full video to find out more about how SBX is different from another popular sequencing technology! go.roche.com/xsbxs #Genomics #HumanGenetics #RocheSBX #Innovation #NGS

MEDIA - We’re pleased to share new Phase III data at #ACTRIMSForum for our investigational medicine in primary progressive multiple sclerosis. 👉roche.com/media/releases $RHHBY $ROG

We fully agree that holistic cancer care must address the entire patient journey, including essential access to pain relief and palliative care. Supporting balanced policies ensures that medical innovation is matched by compassionate, accessible support for those who need it most. #WorldCancerDay #UnitedByUnique Ana at Team Roche

On #WorldCancerDay, we remember that cancer care is more than treatment — it must include pain relief and palliative care. UNODC supports balanced policies to make controlled medicines accessible to patients in need. #PalliativeCare #UNODC

Roche reports strong 2025 results with 7% (CER) sales growth, driven by strong demand for medicines and diagnostic solutions. 👉 Read the full release here: spkl.io/6010AqN8r $ROG $RHHBY #FinancialResults

@AzadBonni @IHB_Research Congratulations, @AzadBonni! With your leadership, the team at @IHB_Research will continue to drive science that patients need. A heartfelt thank you to @HansClevers for your years of dedication and the lasting impact you’ve made. Kat at Team Roche

@IHB_Research @HansClevers I am super excited to take on this additional new role at @Roche to lead the @IHB_Research! It is an honor to build on the legacy of @HansClevers at IHB, and I am looking forward to lead #TeamIHB as we embark on the journey ahead!

✨We are pleased to announce our new Global Head and Director @AzadBonni✨This transition marks a meaningful moment in our journey to advance drug discovery and development through human-centric science. Azad succeeds @HansClevers to lead us as we move into the next phase of IHB.

It's #CervicalCancerAwarenessMonth & we need to face the facts: No woman should die from cervical cancer. This disease is highly preventable, yet hundreds of thousands of families still experience this devastating loss every year. #ScreeningSavesLives

@Marceviejo @Marceviejo, gracias por avisarnos. Hemos verificado que el formulario funciona correctamente. Te sugerimos intentar borrar caché y cookies del navegador. Si el problema persiste, por favor envíanos un mensaje privado con más detalles para poder ayudarte. Ken del Equipo Roche

@Roche Me mandan a llenar un formulario que no existe. Están fabricando basura.

#MEDIA – We are pleased to announce that the US FDA has approved our bispecific antibody for subcutaneous administration, for people with relapsed or refractory #lymphoma, reducing administration time from 2-4 hours to approximately one minute. spkl.io/6011AY8Af $RHHBY $ROG

Thank you for getting in touch with us. Please submit your complaint via this contact form: accu-chek.com/contact as they will be able to support you best. Additionally, you can get in touch with our Diabetes Care office in your country to get additional guidance. Here is a link with a list of all our offices around the world: roche.com/about/business… Wishing you all the best, Ken at Team Roche

@Roche TERRIBLE SHIT. Made in Argentina mother fuckers!

Do you know how mass spectrometry can be used for therapeutic drug monitoring? Enter a new dimension in mass spectrometry and find out how this diagnostic technique can help critically ill patients attain target concentrations. go.roche.com/xtdms #RocheMassSpec